About
Thomas Hummel is a Professor in the Faculty of Life Sciences at [University Name Unknown], specializing in Neuroscience and Developmental Biology. His research focuses on molecular mechanisms of neurotransmitter systems, particularly dopamine and GABA transporters, using Drosophila melanogaster as a model organism. Key interests include epilepsy pathogenesis linked to GABA transporter mutations, serotonin transporter inhibition, and pharmacological chaperone applications.
He has led or collaborated on projects such as 'Neuronal circuits in health and disease' (2024–2029) and 'Interrogating the fate of dopamine transporter mutants by pharmacochaperones' (2018–2022). His work contributes to UN Sustainable Development Goals related to good health and well-being (SDG 3).
Recent publications (2022–2023) explore serotonin transporter inhibition mechanisms, GABA transporter variants in epilepsy, and molecular links between GABA dysfunction and developmental disorders. He actively engages in academic activities, including poster presentations on neuronal lineage functions (2020) and invited talks on interhemispheric brain circuitry (2018).
Media engagements include explaining neurological findings in public outreach articles such as 'Kommissur: menschliches LICAM entspricht Neuroglian der Fruchtfliege' (2019) and 'Nervenzellen-Oberflaechenstoff verkabelt rechte mit linker Hirnhaelfte' (2019).
